Searched for
CARDIAC DRUGS GROWTH
These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsIn just a few days, the Q1 earnings season for FY27 will start. But before that will come the season of business updates. And that needs to...- For low risk-takers: 5 large-caps from different sectors with an upside potential of up to 31%Now, there is nothing wrong with being bullish, because it has always paid to be bullish. Yes, one might argue that it has not paid in the ...
- These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Quadria, PE funds eye stake in Samarth Lifesciences; deal may value firm at Rs 4,500 croreQuadria Capital is eyeing a strategic acquisition of a majority interest in Samarth Lifesciences, a move that could value the transaction a...
- Cardiac drugs log highest sales in 2025 as NCD cases surgeHeart medicines led sales in 2025, a trend set to continue. Respiratory and anti-diabetes drugs followed. Cardiac drug sales grew 13%, with...
- Pharma market in good health; lifestyle diseases may be risingThe other leading molecules in the same segment, like rosuvastatin and telmisartan, continued to grow in line with the therapy segment, the...
- GSK's antibiotic drug Augmentin is India's highest-selling brand with Rs 80 crore monthly saleEnhertu, a cancer drug by AstraZeneca, was the top-selling new drug in 2024 with sales of nearly Rs 58 crore. Over 3,100 new brands were la...
- Amid pollution woes, Asthma drug demand drives pharma retail market growth in NovemberIndia's pharmaceutical retail market rebounded in November with double-digit growth, fueled by increased demand for dermatological, cardiac...
- Pharma market picks up pace, sees 10% value growth in NovIndia's pharmaceutical market rebounded in November with 9.9% value growth and 3.1% volume growth. Key therapy areas like cardiac, gastroin...
- Pharma market sees 6.1% growth in October despite subdued volumesAmongst the top 10 therapies that contribute to more than 90% of the Indian pharma market, price drove growth in the cardiac segment. The a...
- Glenmark launches triple-drug combo for type 2 diabetesGlenmark Pharmaceuticals has launched a triple-fixed-dose combination drug called Zita for the treatment of Type 2 diabetes. The drug, whic...
- Panic buying of drugs down since mid-AprilSales of anti-infective medicines in the April 1-22 period eased to 62% from levels seen from March 1to 22. While sales of antidiabetes dru...
- Drug sales reveal our lifestyle woesIndians spent over Rs 1,36,000 cr on medicines in last one year ending September 2019. People spent over Rs 17,000 cr on cardiac drugs, aro...
- Pharma sector sales growth slump in December quarter“India is an under-diagnosed market, so the argument that less people are falling sick might not be true,” asserts Sujay Shetty, head of li...
Load More
